Remove 2014 Remove Magazine Remove Vaccines
article thumbnail

Clive Dix: Rebuilding UK biotech

pharmaphorum

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. But Dix has also been leading the UK’s Vaccine Taskforce, after taking over the hot seat in December following the departure of Kate Bingham.

article thumbnail

Conducting successful commercial research in a primary care setting

pharmaphorum

She began her career in clinical research as a clinical trial assistant for Novartis Vaccines and Diagnostics in 2007 and continued to pursue her interest is vaccine research in 2014 when she joined GSK (formerly Novartis Vaccines). Eloise McLennan is the editor for pharmaphorum’s Deep Dive magazine. moderator).